MY161197A - Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions - Google Patents

Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Info

Publication number
MY161197A
MY161197A MYPI2012700660A MYPI2012700660A MY161197A MY 161197 A MY161197 A MY 161197A MY PI2012700660 A MYPI2012700660 A MY PI2012700660A MY PI2012700660 A MYPI2012700660 A MY PI2012700660A MY 161197 A MY161197 A MY 161197A
Authority
MY
Malaysia
Prior art keywords
bacillus subtilis
gastro
prophylaxis
treatment
subtilis strain
Prior art date
Application number
MYPI2012700660A
Other languages
English (en)
Inventor
Joseph Earl Schmidt
Desmond Rito Jimenez
Original Assignee
Agraquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agraquest Inc filed Critical Agraquest Inc
Publication of MY161197A publication Critical patent/MY161197A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
MYPI2012700660A 2010-03-17 2011-03-17 Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions MY161197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31499710P 2010-03-17 2010-03-17

Publications (1)

Publication Number Publication Date
MY161197A true MY161197A (en) 2017-04-14

Family

ID=44072771

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012700660A MY161197A (en) 2010-03-17 2011-03-17 Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Country Status (10)

Country Link
US (1) US9457054B2 (enExample)
EP (1) EP2547348B1 (enExample)
JP (1) JP5830084B2 (enExample)
AU (1) AU2011227226B2 (enExample)
DK (1) DK2547348T3 (enExample)
ES (1) ES2550059T3 (enExample)
MY (1) MY161197A (enExample)
NZ (1) NZ603065A (enExample)
PL (1) PL2547348T3 (enExample)
WO (1) WO2011116155A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20120074A1 (es) 2008-09-17 2012-02-26 Agraquest Inc Composicion que comprende cepa de bacillus subtilis para alimentar animales
DK2547348T3 (da) 2010-03-17 2015-08-24 Bayer Cropscience Lp Fremgangsmåde til anvendelse af en bacillus subtilis-stamme til profylakse og behandling af mave-tarm-tilstande
JP2014518878A (ja) 2011-05-24 2014-08-07 バイエル クロップサイエンス エルピー ポリエン系殺菌剤と非リボソーム型ペプチドの相乗的組み合わせ及び関連する使用方法
CN104245943A (zh) * 2012-02-21 2014-12-24 杜邦营养生物科学有限公司 包含来自枯草芽孢杆菌的发酵产物的组合物
FR3007654B1 (fr) * 2013-06-27 2015-07-10 Lesaffre & Cie Composition de solute de rehydratation orale contenant des probiotiques
FR3007655B1 (fr) * 2013-06-28 2016-12-23 Lesaffre & Cie Souche bacillus subtilis pour le traitement et/ou la prevention de maladies inflammatoires chroniques
JP6440463B2 (ja) * 2013-11-15 2018-12-19 プリマハム株式会社 抗菌作用を有するバチルス・メチロトロフィカス
JP6671950B2 (ja) * 2015-12-18 2020-03-25 アサヒカルピスウェルネス株式会社 機能性胃腸症改善剤
EP3645751A1 (en) * 2017-06-30 2020-05-06 Evonik Operations GmbH Bacillus subtilis
US12194142B2 (en) 2017-09-25 2025-01-14 Deerland Enzymes, Inc. Bacillus subtilis containing composition for treatment of gastrointestinal irregularity
MY202181A (en) 2018-01-24 2024-04-14 Omnigen Res Llc Bacillus combination for administration to animals
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
BE1027162B1 (nl) * 2019-03-29 2020-11-05 My Res Comm V Bacillus coagulans en Bacillus subtilis voor de preventie en behandeling van functionele gastro-intestinale stoornissen
US11160838B2 (en) 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions
GB201911925D0 (en) * 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62232343A (ja) 1986-04-01 1987-10-12 Kyodo Shiryo Kk 幼豚用配合飼料
JPS63209580A (ja) 1987-02-25 1988-08-31 Karupisu Shokuhin Kogyo Kk バチルス・ズブチリスｃ−３１０２
KR930001383B1 (ko) 1990-10-31 1993-02-27 재단법인 한국화학연구소 신규의 바실러스 서브틸리스 아종 및 이로부터 생산되는 항진균 물질 krf-001 복합체의 용도
US5785990A (en) 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
JP2979294B2 (ja) 1996-10-02 1999-11-15 カルピス株式会社 鳥類卵殻強度増強剤
IL132533A0 (en) * 1997-05-09 2001-03-19 Agraquest Inc A novel strain of bacillus for controlling plant diseases and corn rootworm
US6103228A (en) 1997-05-09 2000-08-15 Agraquest, Inc. Compositions and methods for controlling plant pests
US6015553A (en) 1997-08-22 2000-01-18 Agraquest, Inc. Bacillus subtilis strain for controlling insect and nematode pests
JP3260111B2 (ja) 1997-10-09 2002-02-25 伊藤忠飼料株式会社 鳥類の給餌中止時の体重減少抑制方法及び腸内有害細菌減少方法
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP2000166583A (ja) 1998-10-02 2000-06-20 Shin Nihonsha:Kk 枯草菌等が産生する無機物及びその酸塩と副産物及びその誘導体
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
AR040927A1 (es) 2002-04-10 2005-04-27 Cooperativas Argentinas Cooper Alimento para la crianza de vacunos neonatos y procedimiento de utilizacion.
AT413191B (de) 2002-10-11 2005-12-15 Erber Ag Futtermittel- und/oder trinkwasserzusatz für nutztiere
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
EP1472933A1 (en) 2003-05-01 2004-11-03 Chr. Hansen A/S Improving health and/or nutritional status of an aquatic animal by aid of Bacillus licheniformis
WO2005010052A2 (en) 2003-07-24 2005-02-03 Cargill, Incorporated Enhanced steep-water
RU2266747C1 (ru) 2004-03-22 2005-12-27 Кубанский государственный аграрный университет Пробиотическая композиция для животных и птицы
JP2007054041A (ja) 2005-07-29 2007-03-08 Yodorinon Kenkyusho:Kk 養鶏飼料並びに卵
US20080057047A1 (en) 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
JP4968816B2 (ja) * 2006-03-08 2012-07-04 日本曹達株式会社 バチルス属細菌の芽胞形成方法
US20070298013A1 (en) * 2006-06-23 2007-12-27 Altman Jay A Animal Nutritional Supplement and Method
EA019915B1 (ru) * 2007-09-20 2014-07-30 Басф Се Фунгицидная композиция для борьбы с фитопатогенными вредными грибами
PE20120074A1 (es) 2008-09-17 2012-02-26 Agraquest Inc Composicion que comprende cepa de bacillus subtilis para alimentar animales
US8227235B2 (en) 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
DK2547348T3 (da) 2010-03-17 2015-08-24 Bayer Cropscience Lp Fremgangsmåde til anvendelse af en bacillus subtilis-stamme til profylakse og behandling af mave-tarm-tilstande

Also Published As

Publication number Publication date
WO2011116155A1 (en) 2011-09-22
AU2011227226A1 (en) 2012-11-08
PL2547348T3 (pl) 2015-11-30
ES2550059T3 (es) 2015-11-04
EP2547348B1 (en) 2015-05-20
NZ603065A (en) 2014-12-24
JP5830084B2 (ja) 2015-12-09
EP2547348A1 (en) 2013-01-23
AU2011227226B2 (en) 2017-02-16
JP2013522315A (ja) 2013-06-13
US20120328571A1 (en) 2012-12-27
DK2547348T3 (da) 2015-08-24
US9457054B2 (en) 2016-10-04

Similar Documents

Publication Publication Date Title
MY161197A (en) Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
PH12015501581A1 (en) Method for using a bacillus subtilis strain to enhance animal health
IN2012DN00624A (enExample)
MY165579A (en) Synthetic methods for spiro-oxindole compounds
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
MX2013004329A (es) 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3.
IN2012DN03883A (enExample)
IN2012DN01638A (enExample)
IN2012DN00971A (enExample)
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
MY178905A (en) Prevention, treatment and diagnosis of p.gingivalis infection
MX2009013353A (es) Compuestos activadores de telomerasa y metodos para su uso.
MX338032B (es) Composicion nematocida que comprende bacillus subtilis y bacillus licheniformis.
MX347471B (es) Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas.
IN2012DN00639A (enExample)
MY153766A (en) Derivatised proline containing peptide organic compounds as protease inhibitors
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MX2012000006A (es) L-serina para usarse como un farmaco para prevenir y/o tratar una respuesta inflamatoria de la piel.
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX342119B (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MY161544A (en) Fragrance composition having good sleep-inducing effect
MX2013002119A (es) Sustituidas-2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas como moduladores de kcnq2/3.
MX2011013324A (es) Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.